FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2180841177> ?p ?o ?g. }

• W2180841177 endingPage "157" @default.
• W2180841177 startingPage "153" @default.
• W2180841177 abstract "Ketamine, an n-methyl-d-aspartic acid receptor complex antagonist, has been used as an anesthetic and/or analgesic. However, in the past decade, ketamine has been illegally available as a recreational drug in Asian countries and Taiwan. Due to the characteristic of being short-acting, youngsters widely assume that ketamine is not as harmful as other drugs, such as heroin. Consequently, many young patients used this drug for a longer duration before they presented with severe urinary frequency and urgency symptoms. Subsequently, other cases have been reported in Taiwan, Hong Kong, Singapore, Malaysia, and Europe. Ketamine abuse is increasing, with rates of 0.30% in 2006 to 0.40% in 2007 among those in the 16–59 year age group. In general, affected patients tend to be young with a peak age range of 16–35 years. The incidence of lower urinary tract symptoms in ketamine abuse patients is around 30%. The actual underlying pathomechanism of ketamine cystitis (KC) and associated pelvic pain remains unclear. It is speculated that chronic contact and stimulation to the bladder or ureteral mucosa due to metabolites of ketamine will result in submucosal edema, vascular ectasia, fibrosis, detrusor muscle inflammation, and fibrosis. Presentations of KC include remarkable dysuria, urinary frequency/urgency, urge incontinence, and bladder pain. Urine culture usually fails to yield any microbiology in KC with bladder pain alone. The majority of patients can enjoy clinical improvement after cessation of ketamine and urological treatment similar to interstitial cystitis/bladder pain syndrome (IC/BPS). However, patients who are still abusing ketamine and/or who have a longer duration of ketamine abuse might suffer from severe bladder pain, which does not respond to empirical oral or intravesical treatments such as hyaluronic acid. Among these patients, most have a remarkably impaired quality of life and are at risk of developing upper urinary tract damage, including hydronephrosis and kidney injury. To reduce bladder pain, improve quality of life, and avoid further deterioration of renal function, surgical intervention might be indicated." @default.
• W2180841177 created "2016-06-24" @default.
• W2180841177 creator A5038463963 @default.
• W2180841177 creator A5074005288 @default.
• W2180841177 date "2015-09-01" @default.
• W2180841177 modified "2023-10-07" @default.
• W2180841177 title "Ketamine cystitis: Its urological impact and management" @default.
• W2180841177 cites W1486260362 @default.
• W2180841177 cites W1530001578 @default.
• W2180841177 cites W1571883927 @default.
• W2180841177 cites W1793635164 @default.
• W2180841177 cites W1961364466 @default.
• W2180841177 cites W1963822402 @default.
• W2180841177 cites W1975634832 @default.
• W2180841177 cites W1982979040 @default.
• W2180841177 cites W1992051020 @default.
• W2180841177 cites W1994407745 @default.
• W2180841177 cites W1996419739 @default.
• W2180841177 cites W2001264812 @default.
• W2180841177 cites W2002329563 @default.
• W2180841177 cites W2006309184 @default.
• W2180841177 cites W2033193783 @default.
• W2180841177 cites W2051053806 @default.
• W2180841177 cites W2066655743 @default.
• W2180841177 cites W2067659103 @default.
• W2180841177 cites W2074309332 @default.
• W2180841177 cites W2098729095 @default.
• W2180841177 cites W2117805758 @default.
• W2180841177 cites W2124487868 @default.
• W2180841177 cites W2138114150 @default.
• W2180841177 cites W2145122020 @default.
• W2180841177 cites W2150817857 @default.
• W2180841177 cites W2398544422 @default.
• W2180841177 doi "https://doi.org/10.1016/j.urols.2014.11.003" @default.
• W2180841177 hasPublicationYear "2015" @default.
• W2180841177 type Work @default.
• W2180841177 sameAs 2180841177 @default.
• W2180841177 citedByCount "21" @default.
• W2180841177 countsByYear W21808411772016 @default.
• W2180841177 countsByYear W21808411772017 @default.
• W2180841177 countsByYear W21808411772018 @default.
• W2180841177 countsByYear W21808411772019 @default.
• W2180841177 countsByYear W21808411772020 @default.
• W2180841177 countsByYear W21808411772021 @default.
• W2180841177 countsByYear W21808411772022 @default.
• W2180841177 countsByYear W21808411772023 @default.
• W2180841177 crossrefType "journal-article" @default.
• W2180841177 hasAuthorship W2180841177A5038463963 @default.
• W2180841177 hasAuthorship W2180841177A5074005288 @default.
• W2180841177 hasBestOaLocation W21808411771 @default.
• W2180841177 hasConcept C121608353 @default.
• W2180841177 hasConcept C126322002 @default.
• W2180841177 hasConcept C126894567 @default.
• W2180841177 hasConcept C141071460 @default.
• W2180841177 hasConcept C1862650 @default.
• W2180841177 hasConcept C2776235491 @default.
• W2180841177 hasConcept C2776845205 @default.
• W2180841177 hasConcept C2778508898 @default.
• W2180841177 hasConcept C2779478474 @default.
• W2180841177 hasConcept C2780136519 @default.
• W2180841177 hasConcept C2780795376 @default.
• W2180841177 hasConcept C2781118164 @default.
• W2180841177 hasConcept C42219234 @default.
• W2180841177 hasConcept C71924100 @default.
• W2180841177 hasConcept C77411442 @default.
• W2180841177 hasConceptScore W2180841177C121608353 @default.
• W2180841177 hasConceptScore W2180841177C126322002 @default.
• W2180841177 hasConceptScore W2180841177C126894567 @default.
• W2180841177 hasConceptScore W2180841177C141071460 @default.
• W2180841177 hasConceptScore W2180841177C1862650 @default.
• W2180841177 hasConceptScore W2180841177C2776235491 @default.
• W2180841177 hasConceptScore W2180841177C2776845205 @default.
• W2180841177 hasConceptScore W2180841177C2778508898 @default.
• W2180841177 hasConceptScore W2180841177C2779478474 @default.
• W2180841177 hasConceptScore W2180841177C2780136519 @default.
• W2180841177 hasConceptScore W2180841177C2780795376 @default.
• W2180841177 hasConceptScore W2180841177C2781118164 @default.
• W2180841177 hasConceptScore W2180841177C42219234 @default.
• W2180841177 hasConceptScore W2180841177C71924100 @default.
• W2180841177 hasConceptScore W2180841177C77411442 @default.
• W2180841177 hasIssue "3" @default.
• W2180841177 hasLocation W21808411771 @default.
• W2180841177 hasOpenAccess W2180841177 @default.
• W2180841177 hasPrimaryLocation W21808411771 @default.
• W2180841177 hasRelatedWork W119038581 @default.
• W2180841177 hasRelatedWork W2035146340 @default.
• W2180841177 hasRelatedWork W2079220961 @default.
• W2180841177 hasRelatedWork W2108209151 @default.
• W2180841177 hasRelatedWork W2342441370 @default.
• W2180841177 hasRelatedWork W2412763479 @default.
• W2180841177 hasRelatedWork W154918438 @default.
• W2180841177 hasRelatedWork W1892796521 @default.
• W2180841177 hasRelatedWork W2304944894 @default.
• W2180841177 hasRelatedWork W2978433466 @default.
• W2180841177 hasVolume "26" @default.
• W2180841177 isParatext "false" @default.
• W2180841177 isRetracted "false" @default.
• W2180841177 magId "2180841177" @default.

• next